Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Cancer Type/Condition:
Pheochromocytoma
Stage/Subtype:
regional pheochromocytoma
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
06-2247
, NCT00442533
2.
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Over 1
Sponsor:
Other
Protocol IDs:
MSKCC-04148
, NCT00107289
3.
RAD001 and Erlotinib in Patients With Neuroendocrine Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CC#084511
, NCT00843531
4.
Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
SU-03272009-2039
, END0008, NCT00947167
5.
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
2 to 25
Sponsor:
NCI
Protocol IDs:
UIHC-200008086
, NCI-V02-1710, NCT00049023, 200008086
6.
Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
N05-10564
, NCT00314925
7.
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
08-087
, NCT00804336
Select All on Page
Help with Results
